论文部分内容阅读
由于抗结核药物的应用,结核病的治疗进入一个新的时期,结核病的病死率显著下降,但是在长期治疗过程中,出现一个问题:结核杆菌对抗结核药物逐渐产生了耐药性,影响药物的疗效,并且已具耐药性的结核杆菌感染其他人群后,进一步造成治疗上的困难,因而对结核病的流行病学带来了新的问题。从应用抗结核药物治疗患者的结核病灶或分泌物中培养出耐药的结核杆菌,称为续发性耐药,而从没有应用抗结核药物治疗过的原发
Due to the application of anti-tuberculosis drugs, the treatment of tuberculosis has entered a new era and the mortality rate of tuberculosis has dropped remarkably. However, during the long-term treatment, a problem arises: Mycobacterium tuberculosis gradually has resistance to tuberculosis drugs and affects the curative effect of the drugs , And the emergence of drug-resistant Mycobacterium tuberculosis infects other populations, further contributing to the therapeutic difficulties that have created new problems for the epidemiology of tuberculosis. Tuberculosis or secretions from patients treated with anti-TB drugs to develop drug-resistant Mycobacterium tuberculosis, known as the renewal of resistance, but never used anti-TB drugs treated primary